paclitaxel has been researched along with Myelodysplastic Syndromes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, R; Kawamura, N; Kawanishi, M; Murakami, M; Nagatsuji, M; Okajima, S; Suruga, M; Tokuyama, O; Yamane, T | 1 |
| Furukawa, Y; Ito, R; Iwama, A; Iwano, S; Kayamori, K; Koide, S; Lennox, W; Mimura, N; Miyawaki, A; Nagai, Y; Nakajima-Takagi, Y; Oshima, M; Sakaida, E; Sheedy, J; Shinoda, D; Tohyama, K; Weetall, M; Yamaguchi, K; Yamazaki, S; Zhong, C | 1 |
| Mladenovska, K; Petrusevska, M; Petrushevska, G; Stavridis, IP | 1 |
| Iida, K; Ishibashi, T; Ishikawa, M; Katagiri, A; Katagiri, H; Miyazaki, K; Nakayama, K; Nakayama, N; Rahman, M; Rahman, MT | 1 |
| Abe, A; Ikawa, H; Maeda, Y; Muguruma, H | 1 |
| Asbell, SO; Bae, K; Kerlin, KJ; Michalski, JM; Pienta, KJ; Rajan, R; Rosenthal, SA; Sandler, HM; Sobczak, ML | 1 |
| Christodoulou, J; Haferlach, T; Schnittger, S; Schoch, C | 1 |
| Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
| Berry, DA; Budman, DR; Cirrincione, C; Citron, ML; Henderson, IC; Hudis, CA; Muss, HB; Norton, L; Winer, EP | 1 |
2 trial(s) available for paclitaxel and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Estramustine; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Paclitaxel; Prostatic Neoplasms; Thromboembolism | 2009 |
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel | 2007 |
7 other study(ies) available for paclitaxel and Myelodysplastic Syndromes
| Article | Year |
|---|---|
[A Case of Myelodysplastic Syndrome Developed during Chemotherapy for Postoperative Recurrent Ovarian Cancer That Progressed to Acute Myeloid Leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Female; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Ovarian Neoplasms; Paclitaxel; Quality of Life | 2023 |
Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndrome.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Decitabine; G2 Phase; Heterografts; HL-60 Cells; Humans; Mice; Myelodysplastic Syndromes; Paclitaxel; Pyrazines; Sequence Analysis, RNA; Tubulin; Tubulin Modulators; Vincristine | 2020 |
Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Examination; Carboplatin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Myelodysplastic Syndromes; Paclitaxel; Risk Factors; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cerebral Infarction; Chemoradiotherapy; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Myelodysplastic Syndromes; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Ovarian Neoplasms; Paclitaxel | 2014 |
[Secondary myelodysplasia and leukemia following carboplatin and paclitaxel-containing chemotherapy for ovarian cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Leukemia; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Treatment Failure | 2008 |
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Paclitaxel | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |